Admission serum albumin concentrations and response to nutritional therapy in hospitalised patients at malnutrition risk: Secondary analysis of a randomised clinical trial

Autor: Céline Bretschera, Fabienne Boesiger, Nina Kaegi-Braun, Lara Hersberger, Dileep N. Lobo, David C. Evans, Pascal Tribolet, Filomena Gomes, Claus Hoess, Vojtech Pavlicek, Stefan Bilz, Sarah Sigrist, Michael Brändle, Christoph Henzen, Robert Thomann, Jonas Rutishauser, Drahomir Aujesky, Nicolas Rodondi, Jacques Donzé, Zeno Stanga, Beat Mueller, Philipp Schuetz

Publikováno v: EClinicalMedicine, Vol 45, Iss , Pp 101301- (2022)

Summary: Background: Historically, admission serum albumin concentrations have been considered useful biochemical markers for nutrition assessment. However, there is a lack of randomised trial data investigating whether low albumin concentrations are

Externí odkaz: https://doaj.org/article/1ea669bf0c974fc2964bc1042610862e

Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumonia

Autor: Thomas Baumgartner, Giedré Zurauskaité, Yannick Wirz, Marc Meier, Christian Steuer, Luca Bernasconi, Andreas Huber, Mirjam Christ-Crain, Christoph Henzen, Claus Hoess, Robert Thomann, Werner Zimmerli, Beat Mueller, Philipp Schuetz

Publikováno v: BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-8 (2018)

Abstract Background Oxidative stress is a modifiable risk-factor in infection causing damage to human cells. As an adaptive response, cells catabolize Tyrosine to 3-Nitrotyrosine (Tyr-NO2) by nitrosylation. We investigated whether a more efficient re

Externí odkaz: https://doaj.org/article/f65bdb1f0f2e47119e5b5fe381100e17

Evaluation of an algorithm for intensive subcutaneous insulin therapy in noncritically ill hospitalised patients with hyperglycaemia in a randomised controlled trial

Autor: Robert Thomann, Philipp Schütz, Beat Müller, Sabine Thomke, Ronald Schoenenberger, Ulrich Keller

Publikováno v: Swiss Medical Weekly, Vol 143, Iss 2324 (2013)

BACKGROUND: Currently glycaemic targets of 8 mmol/l were randomised to either an intervention group or a control group. The primary endpoint was the time in the glycaemic target range (5.5–7.0 mmol/l) within the first 48 hours. RESULTS: Patients

Externí odkaz: https://doaj.org/article/d97a3c2f046f4c4fbc6a09314c9fcb1e

Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland

Autor: François R Jornayvaz, Nicola Alexander-David, Robert Thomann, Stefan Zechmann

Publikováno v: Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 13:2359-2365

Introduction Insulin glargine 300 U/mL (Gla-300; Toujeo®) is a second-generation once-daily basal insulin. Previous randomized controlled trials showed comparable HbA1c reductions with lower rates of hypoglycemia of Gla-300 versus Gla-100. Patients

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8bf1c5a3d9f5ed3a3b77b6f5abd5500f
https://doi.org/10.2147/dmso.s252667

Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: secondary analysis of a prospective randomized trial

Autor: Filomena Gomes, Philipp Schuetz, Christoph Henzen, Laura Bargetzi, Jaques Donzé, C. Brack, Michael Brändle, Robert Thomann, Sarah Sigrist, Vojtech Pavlicek, Nicolas Rodondi, Stefan Bilz, Mario Bargetzi, Claus Hoess, Drahomir Aujesky, Alessandro Laviano, J. Herrmann, Beat Mueller, Annika Bargetzi, Pascal Tribolet, Jonas Rutishauser, Zeno Stanga, Lara Hersberger, Nina Kaegi-Braun

Publikováno v: Bargetzi, L; Brack, C; Herrmann, J; Bargetzi, A; Hersberger, L; Bargetzi, M; Kaegi-Braun, N; Tribolet, P; Gomes, F; Hoess, C; Pavlicek, V; Bilz, S; Sigrist, S; Brändle, M; Henzen, C; Thomann, R; Rutishauser, J; Aujesky, D.; Rodondi, N.; Donzé, J.; ... (2021). Nutritional support during the hospital stay reduces mortality in patients with different types of cancers: Secondary analysis of a prospective randomized trial. Annals of oncology, 32(8), pp. 1025-1033. Elsevier 10.1016/j.annonc.2021.05.793

Background Nutritional support in patients with cancer aims at improving quality of life. Whether use of nutritional support is also effective in improving clinical outcomes requires further study. Patients and methods In this preplanned secondary an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c76fc77cfa7525fa8fd517e14b14f3
https://pubmed.ncbi.nlm.nih.gov/34428510